UKBI010-A

Code: 66540572-1VL D2-231

Cell Line Description

DerivationPrimary cell type: Fibroblast of dermisPrimary cell developmental stage: AdultLocation of primary tissue procurement: Bonn, G...


read more

Your Price
£1,341.89 EACH
Discontinued
£1,610.27 inc. VAT

Cell Line Description

DerivationPrimary cell type: Fibroblast of dermisPrimary cell developmental stage: AdultLocation of primary tissue procurement: Bonn, GermanyReprogramming methodVector type: IntegratingVector: VirusVirus type: RetrovirusGene list: KLF4MYCPOU5F1SOX2Have the reprogramming vectors been silenced: YesCharacterizationAnalysis of Undifferentiated CellsMarker expression: Alkaline Phosphatase (+)TRA 1-81 (+)SSEA-3 (+)SSEA-4 (+)TRA 1-60 (+)Differentiation potencyEctoderm: Neuroepithelial Stem Cell In vivo teratomaEndoderm: Endoderm In vivo teratomaMesoderm: Mesoderm In vivo teratomaMicrobiology / Virus ScreeningHIV 1: NegativeHIV 2: NegativeHepatitis B: NegativeHepatitis C: NegativeMycoplasma: NegativeGenotypingN/A

General description

Induced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.The EBiSC stem cell bank is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimer’;s Disease, Parkinson’;s Disease, Dementia, Motor Neuron Disease (ALS) - and Huntington’;s Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.

Legal Information

mTeSR is a registered trademark of WiCell Research Institute, Inc.

EBiSC is a trademark of Fraunhofer-Gesellschaft

GELTREX is a registered trademark of Life Technologies Corporation

Matrigel is a registered trademark of Corning, Inc.

Linkage

Note: EAUA and CLIP must be completed before order fulfillment

Additional Cell Line Info EBiSC Access Use Agreement (EAUA) Cell Line Information Pack (CLIP)

Subculture Routine

Surface coating: Matrigel®/Geltrex®Passage method: Enzyme-free cell dissociation / EDTAO2 concentration: 21%CO2 concentration: 5%Culture medium: mTeSR® 1

biological sourcehuman dermis (fibroblast)
descriptionage (5-9)
genderfemale
growth modeadherent (pluripotent)
manufacturer/tradenameEBiSC
relevant disease(s)Dravet syndrome
reprogramming methodretrovirus
shipped indry ice
storage temp.−196°C
This product has met the following criteria: